BridgeMD
Tests treatment safety and results for Stable Angina Pectoris
Official title Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
ClinicalTrials.gov ID: NCT05347069
What this study is testing
What is Aspirin?
Aspirin is an investigational medicine, being studied as a potential treatment for stable angina pectoris.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary...
- Patients for whom consent can be obtained
You likely can't join if
- Patients with history of acute coronary syndromes (ACS)
- Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
- Patients with left main trunk stenosis (≥50%)
- Patients for whom aspirin administration is mandatory
- Patients undergoing antithrombotic therapy other than aspirin
- Patients with atrial fibrillation
See the full eligibility criteria
- Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary angiography but not eligible for coronary revascularization
- Patients for whom consent can be obtained
- Patients with history of acute coronary syndromes (ACS)
- Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
- Patients with left main trunk stenosis (≥50%)
- Patients for whom aspirin administration is mandatory
- Patients undergoing antithrombotic therapy other than aspirin
- Patients with atrial fibrillation
- Patients with history of stroke within six months
- Patients scheduled for major surgical procedures that will require aspirin discontinuation
- Patients with contraindication of aspirin
- Patients expected to have a prognosis of 1 year or less due to comorbidities
- Women of child-bearing potential or women who have a positive pregnancy test at enrolment or randomization
- Patients who are judged by attending physicians to be inappropriate to participate in this study
The study team makes the final eligibility decision.
Where it's taking place
- Kyoto, Japan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kyoto, Japan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.